January « 2017 « Science and Enterprise

Scripps, Pfizer Collaborate on DNA-Coded Drug Discovery

By Alan, on January 10th, 2017%

Drug maker Pfizer Inc. is gaining access to advances in a synthetic chemistry technology developed by Scripps Research Institute that tags compounds with DNA identifiers. . . . → Read More: Scripps, Pfizer Collaborate on DNA-Coded Drug Discovery

Neurology Drug Signals Shown to Help Tooth Repair

By Alan, on January 10th, 2017%

Chemical signals from a drug designed to treat Alzheimer’s disease and other neurological disorders were shown in tests with mice to stimulate stem cells that repair teeth. . . . → Read More: Neurology Drug Signals Shown to Help Tooth Repair

Illumina Partnering with IBM, Phillips on Genomics Tools

By Alan, on January 9th, 2017%

Genomics technology company Illumina Inc. is collaborating with technology enterprises IBM and Royal Phillips to expand its sequencing services in precision medicine for cancer. . . . → Read More: Illumina Partnering with IBM, Phillips on Genomics Tools

Sanofi Licensing Antibody for Autoimmune Diseases

By Alan, on January 9th, 2017%

The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College. . . . → Read More: Sanofi Licensing Antibody for Autoimmune Diseases

MD Anderson Cutting Staff by 1,000

By Alan, on January 6th, 2017%

University of Texas – MD Anderson Cancer Center in Houston says it is cutting its workforce by about 1,000, about 5 percent of its staff. Most of the cuts, 800 to 900 jobs, will be done by layoffs. . . . → Read More: MD Anderson Cutting Staff by 1,000

Ionis Options Cardiac Drugs in $1.5 Billion Deal

By Alan, on January 6th, 2017%

Biotechnology company Ionis Pharmaceuticals is providing drug maker Novartis first access to two experimental drugs for controlling proteins that promote cholesterol and triglycerides, which contribute to heart disease. . . . → Read More: Ionis Options Cardiac Drugs in $1.5 Billion Deal

Precision Health Tech Network Expands, Invests $400M

By Alan, on January 5th, 2017%

Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network. . . . → Read More: Precision Health Tech Network Expands, Invests $400M

Technique Uses Light to Activate Drugs in Blood Cells

By Alan, on January 5th, 2017%

A pharmacology lab developed a process that directs light waves at circulating blood cells to release drugs stored in those cells at precise times and locations. . . . → Read More: Technique Uses Light to Activate Drugs in Blood Cells

Gene Expression Changes Found in Wound Healing Therapy

By Alan, on January 4th, 2017%

A clinical trial to reveal the mechanism of a cell therapy to treat venous skin ulcers found the therapy works by altering the gene expression activity of treated cells to resemble healthy tissue. . . . → Read More: Gene Expression Changes Found in Wound Healing Therapy

Solar Cells Shown Feasible to Power Medical Implants

By Alan, on January 4th, 2017%

Biomedical engineers in Switzerland built and field-tested small solar cells that generated enough energy for implanted medical devices like heart pacemakers. . . . → Read More: Solar Cells Shown Feasible to Power Medical Implants

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise